Eton Pharmaceuticals, Inc.
ETON • NASDAQ
Eton Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sean E. Brynjelsen, with a market cap of $634.1M.
CEOSean E. Brynjelsen
Next Earnings
Upcoming earnings announcement for Eton Pharmaceuticals, Inc.
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.12
Revenue Estimate
$22.3M
Earnings History
Past 12 earnings reports for Eton Pharmaceuticals, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | Q4 2025 | $0.19Est: $0.17 | +11.8% | $21.3MEst: $20.5M | +3.7% |  10-K |
| Nov 6, 2025 | Q3 2025 | $0.04Est: $0.15 | -73.3% | $22.5MEst: $20.5M | +9.5% | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.10Est: $0.02 | -600.0% | $18.9MEst: $16.7M | +13.2% | 10-Q |
| May 13, 2025 | Q1 2025 | $0.07Est: $0.05 | +40.0% | $17.3MEst: $15.1M | +14.2% | 10-Q |
| Mar 18, 2025 | Q4 2024 | -$0.02Est: -$0.02 | 0.0% | $11.6MEst: $10.7M | +9.1% | 10-K |
| Nov 12, 2024 | Q3 2024 | $0.02Est: -$0.01 | +300.0% | $10.3MEst: $9.7M | +6.5% | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.12Est: -$0.07 | -71.4% | $9.1MEst: $9.4M | -3.5% | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.03Est: -$0.07 | +57.1% | $8.0MEst: $8.3M | -4.0% | 10-Q |
| Mar 14, 2024 | Q4 2023 | -$0.09Est: -$0.04 | -125.0% | $7.3MEst: $7.7M | -5.0% | 10-K/A |
| Nov 9, 2023 | Q3 2023 | -$0.02Est: -$0.10 | +80.0% | $7.0MEst: $6.3M | +12.3% | — |
| Aug 10, 2023 | Q2 2023 | $0.18Est: -$0.09 | +300.0% | $12.0MEst: $6.5M | +84.3% | — |
| May 11, 2023 | Q1 2023 | -$0.10Est: -$0.14 | +28.6% | $5.3MEst: $4.6M | +16.3% | — |